Sue Chua

1.2k total citations
27 papers, 714 citations indexed

About

Sue Chua is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sue Chua has authored 27 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Sue Chua's work include Medical Imaging Techniques and Applications (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Prostate Cancer Treatment and Research (6 papers). Sue Chua is often cited by papers focused on Medical Imaging Techniques and Applications (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Prostate Cancer Treatment and Research (6 papers). Sue Chua collaborates with scholars based in United Kingdom, Switzerland and Australia. Sue Chua's co-authors include Mary O’Brien, Gary Cook, Charles Swanton, Bhupinder Sharma, Muhammad Siddique, Sugama Chicklore, Vicky Goh, Paul Bassett, Hoi Yin Loi and Christopher Parker and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

In The Last Decade

Sue Chua

26 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sue Chua United Kingdom	14	424	390	285	78	62	27	714
G. Jerusalem Belgium	4	396 0.9×	236 0.6×	132 0.5×	67 0.9×	78 1.3×	8	642
Zhe Jin China	14	283 0.7×	161 0.4×	185 0.6×	62 0.8×	88 1.4×	37	525
Xindong Sun China	11	248 0.6×	342 0.9×	133 0.5×	55 0.7×	45 0.7×	20	532
Pierpaolo Pastina Italy	17	165 0.4×	211 0.5×	319 1.1×	93 1.2×	69 1.1×	39	599
K. Pigott United Kingdom	14	455 1.1×	509 1.3×	337 1.2×	95 1.2×	120 1.9×	24	863
R. Thödtmann Germany	9	496 1.2×	392 1.0×	221 0.8×	85 1.1×	95 1.5×	11	904
Guang Li China	16	149 0.4×	384 1.0×	406 1.4×	107 1.4×	110 1.8×	60	770
Romain‐David Seban France	16	388 0.9×	233 0.6×	607 2.1×	61 0.8×	98 1.6×	40	850
Andreas Hallqvist Sweden	15	295 0.7×	476 1.2×	256 0.9×	48 0.6×	69 1.1×	43	757
Volker Petersen Germany	9	321 0.8×	441 1.1×	433 1.5×	48 0.6×	126 2.0×	25	854

Countries citing papers authored by Sue Chua

Since Specialization

Citations

This map shows the geographic impact of Sue Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Chua more than expected).

Fields of papers citing papers by Sue Chua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Chua. The network helps show where Sue Chua may publish in the future.

Co-authorship network of co-authors of Sue Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Chua. A scholar is included among the top collaborators of Sue Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Chua. Sue Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tunariu, Nina, Holly Tovey, Emma Hall, et al.. (2023). The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases. European Radiology. 34(2). 1146–1154. 4 indexed citations

Bryant, Annette, Ruwaida Begum, Michael Davidson, et al.. (2022). Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study. Current Oncology. 29(4). 2174–2184.

Metser, Ur, Sue Chua, Bao Ho, et al.. (2019). The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of ¹⁸F-Fluoromethylcholine or ⁶⁸Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy. Journal of Nuclear Medicine. 60(9). 1253–1258. 22 indexed citations

Metser, Ur, Sue Chua, Bao Ho, et al.. (2019). The contribution of multiparametric pelvic and whole body MR to the interpretation of 18F-fluoromethylcholine (FCH) or 68Ga-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy.. 60. 593–593. 2 indexed citations

Murray, Iain, Sarah Chittenden, Ana M. Denis-Bacelar, et al.. (2017). The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 44(11). 1832–1844. 62 indexed citations

Green, Michael, Manikandan Kadirvel, Adam McMahon, et al.. (2016). Radiosynthesis of no-carrier-added meta-[124I]iodobenzylguanidine for PET imaging of metastatic neuroblastoma. Journal of Radioanalytical and Nuclear Chemistry. 311(1). 727–732. 9 indexed citations

Smyth, Elizabeth, Nicholas C. Turner, Alex Pearson, et al.. (2016). Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.. Journal of Clinical Oncology. 34(4_suppl). 154–154. 15 indexed citations

Wong, Kee H., Rafał Panek, Liam Welsh, et al.. (2016). The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with ¹⁸F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Journal of Nuclear Medicine. 57(12). 1843–1850. 41 indexed citations

Cook, Gary, Mary O’Brien, Sugama Chicklore, et al.. (2015). Heterogeneity of 18F-FDG PET uptake: Association with treatment response and prognosis in non-small cell lung cancer treated with erlotinib.. Radiology. 276(3). 5 indexed citations

10.

Smyth, Elizabeth, Nicholas C. Turner, Alex Pearson, et al.. (2015). 145O Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results. Annals of Oncology. 26. ix42–ix42. 2 indexed citations

11.

Cook, Gary, Aslam Sohaib, Robert Huddart, et al.. (2015). The role of 18F-FDG PET/CT in the management of testicular cancers. Nuclear Medicine Communications. 36(7). 702–708. 17 indexed citations

12.

Koh, Dow‐Mu, David J. Collins, Neil P. Jerome, et al.. (2015). Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials. Pediatric Radiology. 45(11). 1600–1615. 3 indexed citations

13.

Welsh, Liam, Rafał Panek, Dualta Mcquaid, et al.. (2015). Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. Radiation Oncology. 10(1). 112–112. 16 indexed citations

14.

Gaykema, Sietske B.M., Carolien P. Schröder, Joanna Vitfell-Rasmussen, et al.. (2014). 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients. Clinical Cancer Research. 20(15). 3945–3954. 95 indexed citations

15.

Boer, Richard de, Jane Beith, Jacquie Chirgwin, et al.. (2014). Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives. Asia-Pacific Journal of Clinical Oncology. 10(S4). 15–25. 1 indexed citations

16.

Kraeber‐Bodéré, Françoise, Thomas Carlier, Eliezer Shochat, et al.. (2012). Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by ¹⁸F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials. Journal of Nuclear Medicine. 53(12). 1836–1846. 20 indexed citations

17.

O’Brien, Mary, Jermaine Coward, M. Puglisi, et al.. (2011). A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks. European Journal of Cancer. 48(1). 68–74. 24 indexed citations

18.

Cook, Gary, Aslam Sohaib, Valerie Lewington, et al.. (2010). The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 38(1). 7–13. 44 indexed citations

19.

Cook, Gary, Gopinath Gnanasegaran, & Sue Chua. (2009). Miscellaneous Indications in Bone Scintigraphy: Metabolic Bone Diseases and Malignant Bone Tumors. Seminars in Nuclear Medicine. 40(1). 52–61. 11 indexed citations

20.

Yau, Thomas, Charles Swanton, Sue Chua, et al.. (2006). Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncologica. 45(2). 196–201. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact